(Q34605798)

3 August 2017

title

Oxcarbazepine-induced Stevens-Johnson syndrome: a case report (English)

1 reference

3 August 2017

main subject

Stevens–Johnson syndrome

1 reference

Lung-Chang Lin

1

1 reference

3 August 2017

Ping-Chin Lai

series ordinal

2

1 reference

3 August 2017

Sheau-Fang Yang

series ordinal

3

1 reference

3 August 2017

Rei-Cheng Yang

series ordinal

4

1 reference

3 August 2017

publication date

1 February 2009

1 reference

Kaohsiung Journal of Medical Sciences

3 August 2017

published in

1 reference

3 August 2017

volume

25

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

82-86

1 reference

Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

Medical genetics: a marker for Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

Carbamazepine--the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

Human leukocyte antigens and drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970045-2

7 January 2021

10.1016/S1607-551X(09)70045-2

Identifiers

DOI

1 reference

3 August 2017

1 reference